Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Shaw

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
BJU International|April 19, 2026
Deep learning for fluorescence confocal microscopy image interpretation in radical prostatectomyLixiang Fang, Nikhil Mayor, Alexander Light, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical ProstatectomyEoin Dinneen, Clare Allen, Tom Strange, et al.
The Prostate|February 27, 2019
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimensSusan Heavey, Helena Costa, Hayley Pye, et al.
Frontiers in Cell and Developmental Biology|January 25, 2021
The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA SequencingTianyu Guo, Yang Wang, Jing Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate CancerHarveer Dev, Mark Linch, Krishna Narahari, et al.
Trials|July 22, 2022
NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancerEoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, et al.
Scottish Medical Journal|January 18, 2021
Current process and outcomes of the surgical management of LUTS due to benign prostatic enlargement: how consistent are we? - results from the multi-institutional audit of surgical management of BPE (AuSuM BPE) in the United KingdomHrishi Joshi, Gaurav Sali, Louise Paramore, et al.
Nature Communications|August 31, 2017
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancerMohammad Asim, Firas Tarish, Heather I Zecchini, et al.
European Urology|December 3, 2013
A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patientsPrasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F Shariat, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
BJU International|April 19, 2026
Deep learning for fluorescence confocal microscopy image interpretation in radical prostatectomyLixiang Fang, Nikhil Mayor, Alexander Light, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical ProstatectomyEoin Dinneen, Clare Allen, Tom Strange, et al.
The Prostate|February 27, 2019
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimensSusan Heavey, Helena Costa, Hayley Pye, et al.
Frontiers in Cell and Developmental Biology|January 25, 2021
The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA SequencingTianyu Guo, Yang Wang, Jing Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate CancerHarveer Dev, Mark Linch, Krishna Narahari, et al.
Trials|July 22, 2022
NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancerEoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, et al.
Scottish Medical Journal|January 18, 2021
Current process and outcomes of the surgical management of LUTS due to benign prostatic enlargement: how consistent are we? - results from the multi-institutional audit of surgical management of BPE (AuSuM BPE) in the United KingdomHrishi Joshi, Gaurav Sali, Louise Paramore, et al.
Nature Communications|August 31, 2017
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancerMohammad Asim, Firas Tarish, Heather I Zecchini, et al.
European Urology|December 3, 2013
A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patientsPrasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F Shariat, et al.
Pageof 12